INNOVATE Corp. (NYSE:VATE – Get Free Report) saw a significant drop in short interest in September. As of September 15th, there was short interest totalling 217,800 shares, a drop of 13.0% from the August 31st total of 250,400 shares. Based on an average trading volume of 57,600 shares, the short-interest ratio is currently 3.8 days. Approximately 4.4% of the company’s stock are short sold.
INNOVATE Price Performance
Shares of VATE stock opened at $3.95 on Friday. INNOVATE has a 1-year low of $3.53 and a 1-year high of $16.90. The firm has a fifty day moving average of $3.03 and a two-hundred day moving average of $1.48. The firm has a market cap of $51.55 million, a P/E ratio of -7.05 and a beta of 2.47.
INNOVATE (NYSE:VATE – Get Free Report) last released its earnings results on Wednesday, August 7th. The company reported $0.10 earnings per share for the quarter. The business had revenue of $313.10 million for the quarter.
Institutional Inflows and Outflows
INNOVATE Company Profile
INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; and 3-D building information modeling and detailing for commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants.
Featured Stories
- Five stocks we like better than INNOVATE
- Short Selling: How to Short a Stock
- CarMax’s Impressive Rally: What Investors Should Watch Next
- The Most Important Warren Buffett Stock for Investors: His Own
- MarketBeat Week in Review – 9/23 – 9/27
- Health Care Stocks Explained: Why You Might Want to Invest
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for INNOVATE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INNOVATE and related companies with MarketBeat.com's FREE daily email newsletter.